魯西化工(000830.SZ)上半年淨利預增1027.88%-1072.11%
格隆匯6月29日丨魯西化工(000830.SZ)披露2021年半年度業績預增公吿,公司預計2021年1-6月實現歸屬於上市公司股東的淨利潤25.50億元-26.50億元,同比增長1027.88%-1072.11%。
受益於國內國際雙循環戰略的實施及化工產品市場供求關係等多種因素影響,報吿期內,公司嚴抓安全環保節能管控,確保了生產裝置安、穩、長、滿、優。公司把握市場機遇,發揮園區一體化優勢,保持主要化工產品的產能發揮,主要化工產品價格同比有較大幅度增長,實現業績同比較大幅度上升。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.